Clinical Trial: Real-world outcomes and early progression prediction of first-line systemic therapy in advanced/unresectable pancreatic ductal adenocarcinoma: an retrospective cohort study (RWS-01) (China)

Posted On: 2026-09-29

China, Sept. 29 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Real-world outcomes and early progression prediction of first-line systemic therapy in advanced/unresectable pancreatic ductal adenocarcinoma: an retrospective cohort study (RWS-01)'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133499

Registration Time: 2026/09/28

Type: Observational study

Primary Sponsor: Sun Yat-sen Memorial Hospital, Sun Yat-sen University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=345541

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Real-world outcomes and early progression prediction of first-line systemic therapy in advanced/unresectable pancreatic ductal adenocarcinoma: an retrospective cohort study (RWS-01) (China)